SCHEMBL5248683

SCHEMBL5248683

Cc1cc(OC(F)(F)F)cc(C(=O)Nc2cccc(OC3CCNCC3)c2)c1-c1ccccc1

nearest known ligand 0.44

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
KCNH2 Q12809 1/20 0.44
GSK3B P49841 1/20 0.43
DYRK1A Q13627 1/20 0.43
BRD4 O60885 1/20 0.42
CREBBP Q92793 1/20 0.42
P2RX1 P51575 1/20 0.42
KCNK3 O14649 4/20 0.41
KCNK9 Q9NPC2 4/20 0.41
NPC1 O15118 1/20 0.41
RAB9A P51151 1/20 0.41
SCN8A Q9UQD0 3/20 0.41
SCN10A Q9Y5Y9 3/20 0.41
F10 P00742 1/20 0.41
BRAF P15056 2/20 0.40
EPHX2 P34913 1/20 0.40
KDM4E B2RXH2 1/20 0.40
GAA P10253 1/20 0.40
SMO Q99835 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3289033 0.87 NPC1 (0.46) KCNH2GSK3BDYRK1ABRD4CREBBP
SCHEMBL5144228 0.87 EPHX2 (0.45) KCNH2EPHX2
SCHEMBL5145627 0.86 EPHX2 (0.43) SCN8ASCN10AEPHX2
SCHEMBL5298159 0.85 MAPT (0.44)
SCHEMBL5143816 0.84 PRKAA2 (0.41) P2RX1
SCHEMBL5142098 0.84 KMT2A (0.45) KCNH2EPHX2
SCHEMBL3290058 0.83 CFD (0.42) KCNH2KCNK3KCNK9EPHX2
SCHEMBL3289653 0.83 EPHX2 (0.42) EPHX2
SCHEMBL5144180 0.83 PRKAA2 (0.41) P2RX1BRAFEPHX2
SCHEMBL3289992 0.83 EPHX2 (0.46) KCNH2EPHX2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1753721-A1 AROYL-O-PIPERIDINE DERIVATIVES FOR THE TREATMENT OF DIABETES-RELATED PROBLEMS MERCK PATENT GmbH (DE) 2007-02-21 EP disclosed
WO-2005121091-A1 AROYL-O-PIPERIDINE DERIVATIVES FOR THE TREATMENT OF DIABETES-RELATED PROBLEMS MERCK PATENT GMBH (DE) 2005-12-22 WO disclosed